PFG vs RXRX · P/E 16, rev $15.63B vs rev $14.1M
Principal Financial Group Inc (PFG) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported PFG revenue for 2025-12-31 was $15.63B. Net income was $1.19B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
PFG currently screens at market cap $23.81B and trailing P/E 15.8. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the PFG and RXRX stock pages for the full models.
Not investment advice.